Get startedLog in
    Picture of UCB SA logo

    UCB — UCB SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: UCB: Successful First-In-Patient Trial For Galvokimig In Moderate-To-Severe Atopic Dermatitis

    Picture of UCB SA logoUCB SA
    18/09/2025 07:33
    Sept 18 (Reuters) - Ucb SA UCB.BR:

SUCCESSFUL FIRST-IN-PATIENT TRIAL FOR GALVOKIMIG IN MODERATE-TO-SEVERE ATOPIC DERMATITIS

INITIATION OF PHASE 2B TRIAL IS EXPECTED BY END OF 2025

Source text for Workspace: ID:nNDL13mmzX

Further company coverage: UCB.BR

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on UCB SA

    See all news